Nanogen Issued Patent for Integrated Sample Preparation and Detection Device

SAN DIEGO, March 13 /PRNewswire-FirstCall/ — Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,989,086, “Channel-less Separation of Bioparticles on a Bioelectronic Chip by Dielectrophoresis” by the U.S. Patent and Trademark Office. The ‘086 patent relates to a method of separating biomolecules or cell particles on a chip using electronic current to preferentially attract specific molecules or cellular components.

Source: Nanogen, Inc.